Contribution of the R8 substituent to the in vitro antibacterial potency of besifloxacin and comparator ophthalmic fluoroquinolones

by Haas W, Sanfilippo CM, Hesje CK, Morris TW
Published 2013-05-01

LOW-POWER FAULT-TOLERANT MICROPROCESSOR-BASED DISTRIBUTED ARCHITECTURE FOR ON-BOARD SIGNAL PROCESSING

by Haas, W. H., Liao, H. H., Schoknecht, W. E.
Published 1983

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: etiology of bacterial conjunctivitis and antibacterial susceptibility prof...

by Haas W, Gearinger LS, Usner DW, DeCory HH, Morris TW
Published 2011-09-01

Settlement-Size Scaling among Prehistoric Hunter-Gatherer Settlement Systems in the New World

by Haas, W. Randall, Klink, Cynthia J., Maggard, Greg J., Aldenderfer, Mark S.
Published 2015

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

by Morris TW, Gearinger LS, Usner DW, Paterno MR, DeCory HH, Comstock TL, Haas W
Published 2011-09-01